(Identify the specific (Identify the vendor or agent, device, strain, colleague, or specify Drug construct, isotope, etc.) which animals on this Acid protocol will serve as donors) -- Level 7) Nucleic 5) 6) (Item 4) (Item Post-Procedural (Item 4) Biosafety or or Agent (Item agent 3, Agent Agent CDC Recombinant Pre- 2, Agent 8) 1, the Radioactive Contains Routine Enter Biological Euthanasia Toxic (BSL (Item Infectious ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) number of cells, mCi protocol will serve as donors) the xpected to be painful or distressing to the animals? inding agents)__Summary of How Materials will be Administered. Complete the table below for each of the materials shown in the table in Item 1 above: Dose or this (Y/N) (e.g., in Item) Material* mg/kg, Body” the (Identify the CFU, Reason for Anesthesia, Route Frequency Details specific agent, PFU, Diluent* or Administration “Main of or duration device, strain, number of Vehicle* and Expected Under identify admin of admin construct, cells, mCi) Effects tranquilization Further and or isotope, etc.) and (specify of #”, Volume (ml) ACORP “App Administration Location sedation,
(Identify the specific agent, device, strain, construct, isotope, etc.) (Identify the vendor or colleague, or specify which animals on this protocol will serve as donors) Toxic Agent (Item 4) Infectious Agent (Item 5) -- Enter the CDC Biosafety Level (BSL 1, 2, 3, or 4) Biological Agent (Item 6) Radioactive Agent (Item 7) Contains Recombinant Nucleic Acid (Item 8) Routine Pre- or Post-Procedural Drug Euthanasia agent ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) ( ) ( )BSL_ ( ) ( ) ( ) ( ) ( ) number of cells, mCi protocol will serve as donors) the xpected to be painful or distressing to the animals? inding agents)__Summary of How Materials will be Administered. Complete the table below for each of the materials shown in the table in Item 1 above: Material* (Identify the specific agent, device, strain, construct, isotope, etc.) Dose (e.g., mg/kg, CFU, PFU, number of cells, mCi) and Volume (ml) Diluent* or Vehicle* Route of admin Frequency or duration of admin Reason for Administration and Expected Effects Location of Further Details in this ACORP (specify “Main Body” or “App #”, and identify the Item) Administration Under Anesthesia, sedation, or tranquilization (Y/N)
AnimalComponentOfResearchProtocol.docx